You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 8, February 25, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Lipids and Lipid Disorders
 •Genetics, Other
 •Alert me on articles by topic

Genetic Factors in Exceptional Longevity—Reply

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In Reply: In response to Drs Andrikopoulos and Richter, the main finding of our study is that families with exceptional longevity have a lipoprotein signature that includes high levels of HDL cholesterol and large HDL and LDL lipoprotein particle sizes. These lipoprotein phenotypes were demonstrated to be associated with decreased prevalence of hypertension, cardiovascular disease (CVD), and the metabolic syndrome. Our study and other studies1 have clearly documented CVD-protective effects of the same lipoprotein phenotypes. Thus, our finding with respect to exceptional longevity and lipoprotein concentrations and particle sizes appears robust and consistent with the burden of the cardiovascular literature.

Because exceptional longevity has a strong genetic component and offspring of exceptionally long-lived individuals also carried the protective lipoprotein phenotype, we further sought to elucidate a potential genetic link; CETP is an obvious candidate gene given its role in reverse cholesterol transport. Our findings showed a statistical association between homozygosity . . . [Full Text of this Article]

Nir Barzilai, MD
barzilai@aecom.yu.edu

Gil Atzmon, PhD
Institute for Aging Research
Diabetes Research and Training Center

Clyde Schechter, MA, MD
Department of Family Medicine and Community Health

Richard Lipton, MD
Department of Neurology
Albert Einstein College of Medicine
New York, NY

Alan R. Shuldiner, MD
University of Maryland School of Medicine
Baltimore


RELATED ARTICLES

Genetic Factors in Exceptional Longevity
George K. Andrikopoulos and Dimitri J. Richter
JAMA. 2004;291(8):941-942.
EXTRACT | FULL TEXT  

Unique Lipoprotein Phenotype and Genotype Associated With Exceptional Longevity
Nir Barzilai, Gil Atzmon, Clyde Schechter, Ernst J. Schaefer, Adrienne L. Cupples, Richard Lipton, Suzanne Cheng, and Alan R. Shuldiner
JAMA. 2003;290(15):2030-2040.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.